Navigation Links
New Enterprise Forum Celebrates 22nd Anniversary, Presents Annual Entrepreneur Awards to Randal Charlton & Others
Date:2/12/2008

ANN ARBOR, Mich., Feb. 12 /PRNewswire-USNewswire/ -- New Enterprise Forum will celebrate its 22nd year as a resource for Michigan entrepreneurs in conjunction with its annual awards presentations. The event takes place at 5:00 p.m. on Thursday, February 21 at the Holiday Inn North Campus on 3600 Plymouth Road in Ann Arbor, Michigan.

At the event, awards will be given to entrepreneurs in the following categories: Best New Product, Best Business Strategy, and Best Presentation. In addition, Randal Charlton of TechTown will be honored as the 2007 NEF Entrepreneur of the Year.

Randal Charlton's career has been focused on bringing new technologies to the market. From 2000 - 2007, he was founder and CEO of Asterand, a Detroit-based company that specializes in providing human tissue and data for the development of new drugs and diagnostics. Randal took Asterand from a concept to a public company in less than six years; the company now counts as its customers 18 of the top 20 drug companies in the world. Prior to Asterand, Randal was involved in a number of other bioscience ventures.

Randal is currently Interim Director of TechTown, Wayne State University's high technology business incubator park, and is Economic Advisor and Special Assistant to the President of the University. In addition, he is a non-executive director at Genetics Squared and at Gradecheck, and is the Founder of the Michigan Biobank, a not-for-profit that provides biomaterials for research.

Randal advises or is a board member for a number of health, drug discovery, and economic development organizations, and has been recognized by the MEDC, the MVCA, Wayne State University, and other organizations for his accomplishments as an entrepreneur.

Showcase Presentation: Each month, NEF highlights one or more emerging companies and provides them a Showcase Presentation. This month, our Showcase Presenter will be Peter Dresslar, CEO of Torrey Path, which facilitates drug discovery by combining information technology and statistical analysis into research decision support tools.

Open Forum: The evening's presentations are followed by Open Forum, during which attendees have the opportunity to make a 30-second pitch for their company, product/service, or need.

Registration and networking begin at 5:00 p.m. with the program starting at 5:45 p.m. Free to NEF members and journalists, the cost is $20 for non-members, $5 for students. The event is sponsored by NEF stakeholder sponsor, Bank of Ann Arbor; for information, visit http://www.bankofannarbor.com.

ABOUT NEF

Through its hands-on work with entrepreneurs, NEF has been planting the seeds for Michigan's economic prosperity for over two decades. NEF serves Michigan entrepreneurs by linking them with management expertise, venture partners, business services, capital, and other critical resources. NEF also provides free coaching teams who assist entrepreneurs with investor presentations and business planning in preparation for fundraising meetings. For information, visit http://www.NewEnterpriseForum.org.


'/>"/>
SOURCE New Enterprise Forum
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
2. Neogen Acquires Kane Enterprises
3. Reed Group Ltd. Announces Enterprise License for New Zealands Accident Compensation Corporation
4. ViPS Awarded Enterprise Systems Development (ESD) Contract By CMS
5. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
6. Nu Skin Enterprises to Hold 2007 Analyst Day
7. BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
8. EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations
9. E-Rad Solutions Selects Compressus Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market
10. CYIG Awarded Chinas "Top 100 Enterprises" in New Pharmaceuticals, Selected as National "Torch Plan Key High-Tech Enterprise"
11. Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... -- On Thursday, February 11, 2-1-1 San Diego ... and disaster services, and the Community Information Exchange ... coordination and service delivery for the community to better ... better connect service providers to the information they can ... has handled more than 2.5 million connections ...
(Date:2/5/2016)... 5, 2016 Amarantus BioScience Holdings, ... focused on developing products for Regenerative Medicine, Neurology and ... Disease Designation (RPDD) from the US Food and Drug ... MANF was previously granted orphan drug designation (ODD) by ... Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), ...
(Date:2/5/2016)... Feb. 5, 2016 Australian-US drug discovery and development ... the appointment of a new Chairman, Mr John O,Connor ... effective immediately. James Garner , has also ... and former Acting CEO, Mr Iain Ross , will ... --> James Garner , has also been formally ...
(Date:2/4/2016)... San Francisco, CA (PRWEB) , ... February 04, ... ... future of enterprise talent development and compliance training, today announced an interactive ... on Morf Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course ...
Breaking Biology Technology:
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ) ... "Global Facial Recognition Market 2016-2020" report ... ) has announced the addition of the ... report to their offering. --> ... announced the addition of the "Global ...
(Date:2/4/2016)... -- The field of Human Microbiome research and ... hubs of the biotechnology industry. While the Human ... human microbiota, have garnered a lot of attention ... has literally exploded in terms of both basic ... on biomedical aspects of research, development, and commercial ...
(Date:2/3/2016)... --> --> Fourth quarter 2015:   ... compared with fourth quarter of 2014. Gross margin was 46% ... Earnings per share increased to SEK 6.39 (loss: 0.49). ... , --> --> January ... (233.6), up 1,142% compared with 2014. Gross margin was 43% ...
Breaking Biology News(10 mins):